Business

Ryoncil Sales for the Quarter Increase 60% to US$35.1M

Ryoncil Sales for the Quarter Increase 60% to US$35.1M

Mesoblast LimitedJanuary 8, 20265

Ryoncil Sales for the Quarter Increase 60% to US$35.1M

About this update from Mesoblast Limited

Mesoblast Ltd has released a press release. View Attachment

View stock analysis, news, and events for Mesoblast Limited

More from Mesoblast Limited

Mesoblast Reports Substantial Revenue Growth to US$120M

August 26, 2026

Major Milestone Treatment Completed in P3 Trial for CLBP

August 16, 2026

All Mesoblast Limited news →